English | Español
Robert Hadley | Jun 21, 2017

Clinical trial deems AstraZeneca’s Lynparza better for mutation-caused breast cancer than chemotherapy
Ruth de Jauregui | Jun 21, 2017

Health care marketplace forecast brings call for more than just a fix

Ruth de Jauregui | Jun 21, 2017

Medivizor to help LLS Community network supply health infomation to blood cancer patients
Erianne Leatherman | Jun 21, 2017

Lilly says its galcanezumab cuts down on amount of migraine headache days

Ruth de Jauregui | Jun 21, 2017

SCI Solutions upgrades its cloud-based Schedule Maximizer
Robert Hadley | Jun 21, 2017

Mapi Group restructures to amplify patient’s voice in drug testing and design
Ruth de Jauregui | Jun 21, 2017

Study compares original and Next Generation Masimo Patient State Index
Robert Hadley | Jun 20, 2017

Novo Nordisk’s Xultophy better for diabetics than insulin alone, study says

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’